Citigroup’s Kymera Therapeutics KYMR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $391K | Sell |
|
|||||
|
2025
Q2 | $1.25M | Sell |
|
|||||
|
2025
Q1 | $2.22M | Buy |
|
|||||
|
2024
Q4 | $2.59M | Buy |
|
|||||
|
2024
Q3 | $1.64M | Buy |
|
|||||
|
2024
Q2 | $585K | Sell |
|
|||||
|
2024
Q1 | $8.88M | Buy |
|
|||||
|
2023
Q4 | $2.26M | Sell |
|
|||||
|
2023
Q3 | $1.4M | Sell |
|
|||||
|
2023
Q2 | $2.5M | Sell |
|
|||||
|
2023
Q1 | $6.07M | Buy |
|
|||||
|
2022
Q4 | $3.3M | Sell |
|
|||||
|
2022
Q3 | $4.38M | Buy |
|
|||||
|
2022
Q2 | $3.76M | Buy |
|
|||||
|
2022
Q1 | $923K | Sell |
|
|||||
|
2021
Q4 | $5.18M | Buy |
|
|||||
|
2021
Q3 | $3.13M | Sell |
|
|||||
|
2021
Q2 | $4.05M | Buy |
|
|||||
|
2021
Q1 | $2.48M | Buy |
|
|||||
|
2020
Q4 | $126K | Buy |
|